These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 198968

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of blood and feather pulp samples for the diagnosis of Marek's disease and for monitoring Marek's disease vaccination by real time-PCR.
    Cortes AL, Montiel ER, Lemiere S, Gimeno IM.
    Avian Dis; 2011 Jun; 55(2):302-10. PubMed ID: 21793449
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Vaccinating properties of the Kekava 55 strain of attenuated Marek's disease virus].
    Iakovleva LS, Mazurenko NP.
    Vopr Virusol; 1983 Jun; 28(6):689-93. PubMed ID: 6322454
    [Abstract] [Full Text] [Related]

  • 31. Immunity to Marek's disease: where are we now?
    Haq K, Schat KA, Sharif S.
    Dev Comp Immunol; 2013 Nov; 41(3):439-46. PubMed ID: 23588041
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus.
    Haq K, Elawadli I, Parvizi P, Mallick AI, Behboudi S, Sharif S.
    Antiviral Res; 2011 Jun; 90(3):218-26. PubMed ID: 21501630
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of cell-associated vaccines against Marek's disease virus grown in QT35 cells or JBJ-1 cells.
    Geerligs H, Spijkers I, Rodenberg J.
    Avian Dis; 2013 Jun; 57(2 Suppl):448-53. PubMed ID: 23901760
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Heterogeneity of a population of the Kekaya strain of Marek disease virus].
    Iakovleva LS, Zueva IuN, Pavlovskaia AI, Mazurenko NP, Tsvetkov VS.
    Vopr Onkol; 1976 Jun; 22(7):76-81. PubMed ID: 186953
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.